What the GLP-1 protein report examines
A US-focused report published by Men’s Fitness on 12 October 2026 examines how people taking GLP-1 weight-loss medicines can maintain protein and nutrient intake while eating less. Republished by Yahoo Health, it considers muscle preservation alongside evidence about food quality and the limits of claims made for particular meat products.
The practical problem is that appetite suppression does not selectively reduce foods with little nutritional value. People taking semaglutide or tirzepatide may also eat less protein, making it harder to maintain lean tissue during weight loss.
The report cites semaglutide trials in which lean mass accounted for roughly 40 per cent of total weight lost. That figure needs qualification: lean mass includes tissue other than skeletal muscle, so it should not be read as showing that 40 per cent of the loss was muscle.
It also notes disagreement about the significance of those findings, with other analyses suggesting that the proportion is comparable with weight loss through diet alone. The distinction is important to the wider debate over GLP-1 muscle loss: a change in body composition does not, by itself, establish a drug-specific effect on muscle.
The article is nutrition reporting, not a new clinical trial or a change to UK prescribing guidance. Its examination of meat products was prompted by Force of Nature, a company selling minced beef blended with organ meat, whose consultant is quoted in the piece.
Why appetite suppression changes protein needs
Semaglutide, sold as Wegovy for weight management, and tirzepatide, sold as Mounjaro, act on hormone pathways involved in appetite. Semaglutide targets the GLP-1 receptor; tirzepatide acts on both GIP and GLP-1 receptors. Their effects can help people eat less, but do not remove the need for a nutritionally adequate diet.
The report cites sports nutrition guidance of 1.4–2.0 grams of protein per kilogram of body weight daily for people training to build or retain muscle. It separately describes 1.2–1.6 grams per kilogram as a lower target range commonly used by dietitians during weight loss. These are general ranges, not a prescribed intake for every person taking a weight-loss medicine; the article specifically advises medical input for people with kidney disease.
Meeting a target can itself be difficult. Protein promotes fullness, and the report cites a review of randomised trials linking that effect partly to increased natural GLP-1 and reduced ghrelin, a hormone involved in hunger. A person whose appetite is already suppressed may struggle to eat a larger protein portion.
Protein quality is a separate consideration from quantity. The digestible indispensable amino acid score, or DIAAS, assesses how well a protein supplies essential amino acids in a digestible form. Meat, eggs and dairy score highly, according to the report.
Other nutrients also contribute to muscle function. The article discusses vitamin B12, iron, zinc and creatine, rather than treating protein grams as a complete measure of a meal’s value. A 2022 analysis by Ty Beal ranked foods for their density of six micronutrients: iron, zinc, folate, vitamin A, B12 and calcium. Organ meats, small fish and shellfish ranked highest, with beef, eggs and dark leafy vegetables also in the leading group.
The report also cites a 2017 study in which whole eggs stimulated more muscle protein synthesis after exercise than egg whites containing the same amount of protein. That finding concerns a particular food comparison and short-term response; it is not evidence that whole eggs prevent muscle loss in people taking GLP-1 medicines.
What the nutrition consultant says about food quality
Kate Kavanaugh, a certified master nutrition therapist, butcher and farmer who consults for Force of Nature, argues that protein totals alone can overlook the wider nutritional content of food.
“Where people go wrong is treating every gram as interchangeable,” she told the publication.
Her position requires a clear disclosure. Kavanaugh is not a registered dietitian and declined to answer clinical questions about GLP-1 medicines because they were outside her expertise. The source says its clinical discussion and vitamin A warning draw on independent material.
Force of Nature supplied third-party laboratory results showing more B12, riboflavin and copper in its tested organ-meat blends than in standard minced beef. Those results support a comparison of nutrient content in the products tested. They do not establish that the blends preserve muscle better or produce broader health benefits.
Kavanaugh also cautioned that nutrient profiles vary with cattle breed, feed, location, season and rearing conditions. The report describes research finding roughly twice as much conjugated linoleic acid, and higher omega-3 levels, in grass-finished than grain-finished beef. However, a large relative difference can start from a small quantity: beef remains a much less concentrated source of omega-3s than oily fish such as salmon or sardines.
What GLP-1 users should consider before changing their diet
The report’s practical approach combines adequate protein with resistance training, rather than relying on food selection alone. For patients, dietary advice belongs alongside monitoring of Mounjaro side effects, particularly when reduced appetite makes normal meals difficult to manage.
Its most specific warning concerns liver. Preformed vitamin A can accumulate in the body, unlike the beta-carotene found in vegetables. The article cites the US National Institutes of Health adult upper limit of 3,000 micrograms daily and gives about 6,582 micrograms for a three-ounce serving of beef liver. That US reference is not presented as an NHS recommendation.
The vitamin A content of an organ-meat blend depends on its composition and should not be assumed to equal a serving of liver. Nevertheless, regular liver consumption and a multivitamin containing preformed vitamin A can contribute to the same overall intake. The report lists joint and muscle pain, fatigue and liver abnormalities among the consequences of chronic excess.
The open clinical question is whether particular foods or commercial blends improve muscle preservation during GLP-1 treatment. The evidence described does not answer it, and the report sets no timetable for further trials or revised guidance. It advises consulting a qualified professional before changing diet, training or supplements.
